Clinical Trial Update: Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC [Phase 1]

View source ↗

Summary

Phase I trial of bevacizumab plus chemotherapy for malignant pleural effusion in advanced non-small cell lung cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED